Tim Morton // May 2, 2017
At Luxor Scientific we believe in keeping up-to-date on the latest research and trends within the laboratory testing and services industry. The following article was published in the Journal of Medical Economics: “The effect of pharmacogenetic profiling with a clinical decision support tool on healthcare resource utilization and estimated costs in the elderly exposed to polypharmacy”.
In summary this article illustrates how “pharmacogenetic CYP testing reduces healthcare resource utilization, can guide prescription drug treatments, reduce hospitalization and emergency department visits and lower overall costs for elderly patients when they are simultaneously using multiple drugs to treat a single ailment or condition ” (Brixner et al).
Learn more about our Pharmacogenetics Testing Services.